Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
9m agoFatPipe Unveils VeloCloud Replacement Program with Price Match, 15% Discounts and 10% Partner Rebates
36m agoAngle Advisors announces Shift Transit has been recapitalized by Main Street Capital Corporation
36m agoCentury Complete Announces New Homes Coming Soon to Fleming Island, FL
36m agoSprott Physical Copper Trust Announces Preliminary Proxy Results for Unitholder Meeting and Anticipated Listing Date on the NYSE Arca
37m agoTambourine & Hyatt Launch Hyatt Wedding Guide to Revolutionize Digital Wedding Planning
Rocket Pharmaceuticals Inc logo

Rocket Pharmaceuticals Inc

About

Rocket Pharmaceuticals Inc (NASDAQ:RCKT) — investor relations, events, news, and company updates on 6ix.

Latest News

Today
Rocket Pharmaceuticals Announces $180 Million Sale of Priority Review Voucher
Mar 27 2026
Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)
Feb 26 2026
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress
Jan 5 2026
Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Nov 25 2025
Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference

Financials

Revenue
$0
Market Cap
$385.42 M
EPS
-2.01

Community Chat

Ask AI

6ix6ixAIEvents